Skip To Main Content

mobile-menu

logo-container

logo-image

mobile-district-nav

mobile-main-nav

mobile-translate-container

mobile-cta-nav

fixed-header

district-nav-container

sticky-translate-container

search-container

header-container

header-top-container

header-bottom-container

cta-nav

Breadcrumb

What is Multiple Myeloma?

Multiple Myeloma is a cancer of the plasma cells.  This cancer generally develops in people over of the age of 50.  It is the second-most widespread cancer in the United States.  Plasma cells help your body fight infection by producing proteins called antibodies. In Multiple Myeloma, plasma cells grow out of control in the bone marrow and form tumors in the areas of solid bone and body tissue.

Symptoms:

  • bone pain
  • fatigue
  • weight loss
    MMRF
  • infection
  • paleness
  • fever
  • shortness of breath
    • Complications include:
      • kidney failure
      • bone fractures
      • high levels of calcium
      • increased risk of infection

Treatment:

  • Drug Treatments include;
    • Dexamethasone
    • Melphalan
    • Cyclophosphamide
    • Doxorubicin
    • Thalidomide
    • Lenalidomide (Revlimid)
    • Bortezomib (Velcade)
  • Radiation therapy
  • bone marrow transplant

Statistics:

  • lifetime risk of getting it in the United States is .67%
  • in 2013:
    • an expected 22,350 cases will be diagnosed
    • an expected 10,710 deaths will occur due to Multiple Myeloma